State v. Tavares

568 P.3d 608, 339 Or. App. 605
CourtCourt of Appeals of Oregon
DecidedApril 9, 2025
DocketA180879
StatusPublished
Cited by1 cases

This text of 568 P.3d 608 (State v. Tavares) is published on Counsel Stack Legal Research, covering Court of Appeals of Oregon primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
State v. Tavares, 568 P.3d 608, 339 Or. App. 605 (Or. Ct. App. 2025).

Opinion

No. 318 April 9, 2025 605

IN THE COURT OF APPEALS OF THE STATE OF OREGON

STATE OF OREGON, Plaintiff-Respondent, v. ELIJAH SYDNEY TAVARES, Defendant-Appellant. Deschutes County Circuit Court 22CR12038; A180879

Alicia N. Sykora, Judge. Submitted October 22, 2024. Ernest G. Lannet, Chief Defender, Criminal Appellate Section, and Kristin A. Carveth, Deputy Public Defender, Office of Public Defense Services, filed the brief for appellant. Ellen F. Rosenblum, Attorney General, Benjamin Gutman, Solicitor General, and Michael A. Casper, Assistant Attorney General, filed the brief for respondent. Before Aoyagi, Presiding Judge, Egan, Judge, and Joyce, Judge. JOYCE, J. Affirmed. 606 State v. Tavares

JOYCE, J. Defendant appeals from a judgment convicting him of driving under the influence of intoxicants (DUII), ORS 813.010 (2021), amended by Or Laws 2023, ch 498, § 3. In a single assignment of error, defendant contends that the trial court erred in granting the state’s motion in limine to admit evidence related to the content of defendant’s blood, which was drawn after defendant was pulled over for speeding. That evidence consisted of expert testimony from Anderson, a toxicologist who had reviewed the documentation and result of tests that several other lab analysts conducted, and Anderson’s report analyzing the content of defendant’s blood. Defendant argued that Anderson’s testimony and report contained testimonial hearsay statements from the ana- lysts who had conducted the testing, and, consequently, that the admission of that evidence in the absence of the other analysts’ testimony violated his right to confrontation under the Sixth Amendment to the United States Constitution. On appeal, defendant renews those arguments. For the rea- sons stated below, we conclude that any error in admitting Anderson’s testimony and report was harmless. Accordingly, we affirm. The relevant facts are undisputed. Officer Childers stopped defendant for speeding. As he approached defen- dant’s car, Childers smelled an “overwhelming” scent of burnt marijuana coming from defendant’s vehicle. Upon see- ing and interacting with defendant, Childers observed that defendant had droopy eyelids, bloodshot eyes, and dilated pupils, and that his speech was slow and mumbled. Based on those indicators, Childers suspected that defendant was impaired and initiated a DUII investigation. Childers asked defendant when he had last used any sort of cannabis, and defendant responded that he had smoked “one or two bowls” a couple hours prior to driving. When Childers asked defendant to rate himself on a scale from zero to 10, with zero being completely sober and 10 being “the highest [he had] ever been,” defendant rated him- self “like a three.” Defendant agreed to take field sobriety tests, and, during his performance of those tests, Childers observed several validated clues of impairment. Cite as 339 Or App 605 (2025) 607

Childers arrested defendant for DUII and trans- ported him to the hospital, where he obtained a sample of defendant’s blood. Childers then sent defendant’s blood sam- ple to NMS Labs, a large private laboratory in Pennsylvania, and requested that the lab conduct testing entitled “DUID/ DRE Panel ProofPOSITIVE®, Blood.” Before defendant’s trial, the state filed a motion in limine to admit testimony and a report about that test- ing from Anderson, a forensic toxicologist from NMS Labs. Anderson did not participate in or observe the testing of defendant’s sample in the lab. Rather, Anderson’s “main responsibility as a toxicologist with NMS Labs is to sign out reports”—a process that required him to “electronically review” records of all the work that the lab analysts had conducted on defendant’s sample. Based on his review of those records, he wrote and signed a report that he testified “accurately reflect[ed his] analysis of the testing that was done” in defendant’s case. Defendant opposed the state’s motion in limine to admit Anderson’s testimony and report, arguing that its admission would “violate [his] right to confront wit- nesses under the Sixth Amendment of the United States Constitution” because that evidence relied on testimonial hearsay statements of the analysts who participated in test- ing defendant’s sample. At a hearing on the state’s motion to admit the evi- dence, the state offered testimony from Anderson regarding the lab’s testing procedures and the testing of defendant’s sample. According to Anderson, NMS Labs uses an assem- bly line approach in which multiple analysts across different departments handle various testing tasks for each sample. Anderson explained that, for each sample, the lab conducts an initial drug screen, and if the result is positive, the sam- ple is then subjected to a confirmatory test. He described the process of completing those tests in detail. After all the tests for a particular sample are complete, the lab’s information system prepares a draft report with the results and sends it to Anderson for review. In conducting his final review and before signing the report, Anderson checks that “all the test procedures [were] completed,” and he “review[s] the data, 608 State v. Tavares

making sure that * * * the data supports the actual results on the report.” With respect to defendant’s case in particular, Anderson explained that he conducted the final review of the analysts’ tests of defendant’s blood. He determined that defendant’s blood contained an active component of marijuana (delta-9 THC) as well as one active metabo- lite (11-hydroxy delta-9 THC) and one inactive metabolite (delta-9 carboxy THC). Anderson authored and signed a report containing those results. Following the hearing, the court granted the state’s motion to admit Anderson’s testimony and report. The court determined that “Anderson’s report and opinions [were] tes- timonial,” and that “bench analysts’ testimonial evidence [was] not being offered by the State.” Thus, the trial court concluded that “defendant’s right to confront[ation] will be satisfied * * * because Mr. Anderson will be subject to cross examination in trial.” At trial, Childers testified about his interactions with defendant during the traffic stop, including his obser- vations about the smell of marijuana, defendant’s bloodshot eyes, droopy eyelids, and dilated pupils, as well as his slowed speech and performance on the field sobriety tests. Childers further testified, and the state introduced his bodycam video showing, that defendant participated in field sobriety tests, admitted to smoking “one or two bowls” a couple hours before driving, and stated that he was “like a three” on a scale of zero to 10, with 10 representing “the highest [he had] ever been.” Anderson also testified and described the test results, which indicated that defendant had marijuana in his system during the traffic stop. In particular, Anderson explained that defendant’s blood contained delta-9 THC in a concentration of 5.1 nanograms per millimeter. When asked whether that particular concentration of THC would have been enough to impair defendant’s driving, Anderson responded that there was “just no magic number or blood level” that had been shown to be sufficient to impair a per- son’s driving. Anderson further explained that “as a forensic Cite as 339 Or App 605 (2025) 609

toxicologist evaluating drugs on a piece of paper * * * I can- not tell how these drugs would actually affect a particular person.” In Anderson’s view, to be able to tell whether a per- son is actually impaired by marijuana “it has to come from * * * observed behavior, witness behavior, officers interacting with them, field sobriety tests, [or] drug recognition expert tests.” The jury convicted defendant of DUII, and defen- dant now appeals.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

State v. Tavares
339 Or. App. 605 (Court of Appeals of Oregon, 2025)

Cite This Page — Counsel Stack

Bluebook (online)
568 P.3d 608, 339 Or. App. 605, Counsel Stack Legal Research, https://law.counselstack.com/opinion/state-v-tavares-orctapp-2025.